Tourette's Syndrome and Creativity, Exploiting the Ticcy Witticisms and Witty Ticcicisms
BMJ 305:1515-1516, 15631992., Sacks,O., 1992
Adult Tics in Gilles de la Tourett's Syndrome:Description and Risk Factors
Neurol 42:784-788, Goetz,C.G.,et al, 1992
A Controlled Trial of Propoxyphene and Naltrexone in Patients with Tourette's Syndrome
Ann Neurol 30:19-23, Kurlan,R.,et al, 1991
The Coexistence of Tics and Dystonia
Arch Neurol 48:862-865, Stone,L.A.&Jankovic,J., 1991
Cocaine-Associated Multifocal Tics
Neurol 40:999-1000, Pascual-Leone,A.&Dhuna,A., 1990
Sensory Tics in Tourette's Syndrome
Neurol 39:731-734, Kurlan,R.,et al, 1989
Transient Tic Disorder and the Spectrum of Tourette's Syndrome
Arch Neurol 45:1200-1201, Kurlan,R.,et al, 1988
Severity of Tourette's Syndrome in One Large Kindred, Implication for Determination of Disease Prevalence Rate
Arch Neurol 44:268-269, Kurlan,R.,et al, 1987
Pimozide Treatment of Tic & Tourette Disorders
Pediatrics 79:1032-1039, Shapiro,A.K.,et al, 1987
Treatment of Gilles de la Tourette's Syndrome:Experience in a Predominantly Adult Population
Neurol 37:1828-1833, Mesulam,M.M.&Peterson,R.C., 1987
A Rating Scale for Gilles de la Tourette's Syndrome:Description, Reliability, & Validity Data
Neurol 37:1542-1544, Goetz,C.G.,et al, 1987
The Natural History of Tourette Syndrome:A Follow-Up Study
Ann Neurol 22:383-385, Erenberg,G.,et al, 1987
Obsessions & Compulsions in Gilles de la Tourette's Syndrome
Neurol 36:378-382, Frankel,M.,et al, 1986
Cocaine & Tourette's Syndrome
NEJM 315:398, Mesulam,M.M., 1986
The Effects of Sympathomimetic & Antihistaminic Agents on Chronic Motor Tics & Tourette's Disorder
NEJM 315:1228-1229, Shafii,M., 1986
The Inheritance of Gilles De La Tourette's Syndrome & Associated Behaviors
NEJM 315:993-997, Pauls,D.L.&Leckman,J.F., 1986
Gilles de la Tourette's Syndrome, A Review of Clinical, Research & Future Directions for Investigation
Arch Neurol 42:393-397, Caine,E.D., 1985
Short- & Long-Term Treatment of Tourette's Syndrome with Clonidine:A Clinical Perspective
Neurol 35:343-351, Leckman,J.F.,et al, 1985
Pimozide for Tourette's Disorder
Medical Letter 27:3-4, , 1985
Tourette's Syndrome & Migraine
Arch Neurol 41:871-872, Barabas,G.,et al, 1984
Treatment of Tourette's Syndrome with R022-1913, A D-2-Receptor Antagonist
NEJM 311:989, Uhr,S.B.,et al, 1984
Neuro-ophthalmic Abnormalities in Tourette's Syndrome:Functional & Anatomic Implications
Neurol 34:359-361, Frankel,M.,et al, 1984
Effect of Tetrabenazine on Tics & Sleep of Gilles de la Tourette's Syndrome
Neurol 34:688-692, Jankovic,J.,et al, 1984
Senile-Onset Vocal & Motor Tics
Arch Neurol 40:825-826, Sutula,T.,et al, 1983
Long Latency Between the Onset of Motor & Vocal Tics in Tourette's Syndrome
Ann Neurol 14:693-694, Lang,A.E.,et al, 1983
Stimulant Medications Precipitate Tourette's Syndrome
JAMA 247:1168-1169, Lowe,T.L.,et al, 1982
The Electroencephalogram in Tourette Syndrome
Ann Neurol 11:382-385, Bergen,D.,et al, 1982
Tic Disorders
JAMA 245:1583-1585, Shapiro,E.,et al, 1981
Physostigmine In Gilles De La Tourettes Syndrome
NEJM 302:298, Stahl,S.M.,et al, 1980
Gilles de la Tourette Syndrome & Compressive Neuropathies, Letter
Ann Neurol 8:453, Goetz,C.G.,et al, 1980
Haloperidol-Induced Tardive Dyskinesia in a Child With Gilles de la Tourette's Disease
Arch Neurol 37:780, Mizrahi,E.M.,et al, 1980
Familial Tourette Syndrome
Ann Neurol 5:104, Guggenheim,M.A., 1979
Improvement in Gilles de la Tourette Syndrome after Corticosteroid Therapy
Ann Neurol 4:387, Kondo,K.,et al, 1978
Tics & Tourette's:A Continuum of Symptoms
Ann Neurol 4:145-148, Golden,G.S., 1978
Gilles de la Tourette's syndrome:Clinical, Genetic, Psychologic, & Biochemical Aspects in 21 Selected Families
Neurol 27:115, Eldridge,R.,et al, 1977
The Effect of Central Nervous System Stimulants on Tourette Syndrome
Ann Neurol 2:69, Golden,G.S., 1977
Purine Phosphoribosyltransferase in Gilles de la Tourette Syndrome
NEJM 296:210, VanWoert,M.H.,et al, 1977
Clinical Diagnosis of the Dyskinesias
Med Clin of North Am 56:1321, Duvoisin,R., 1972
Systematic Genetic Assessment in Young Patients with Cryptogenic Stroke: The ES-EASY Project
Stroke 57:148-156, Mania-Paris,L.,et al, 2026
Stroke Mechanism and Severity after Left Atrial Appendage Occlusion, Insights from the LAAOS III Randomized Clinical Trial
JAMA Neurol 83:76-82, Katsanos,A.H.,et al, 2026
Intravenous Thrombolysis Use in the Late Time Window Before Interhospital Transfer for Thrombectomy
JAMA Neurol 83:60-67, Seners,P.,et al, 2026
Reversible Leukoencephalopathy and Parkinsonism Due to CNS Involvement in Cryoglobulinemia
Neurol 106:e214622, German,A.,et al, 2026
Clinicopathologic Conference, Disseminated Infection with Hypervirulent Klebsiella Pneumoniae
NEJM 394:282-294, Case 202026, 2026
Disseminated Brain Infarcts Associated with Uterine Myoma
Stroke 57:e61-e62, Elbischger,J.,et al, 2026
Tenecteplase for Acute Non-Large Vessel Occlusion 4.5 to 24 Hours After IschemicStroke, The OPTION Randomized Clinical Trial
JAMA doi:10.1001/JAMA.2026.0210, Ma,G.,et al, 2026
Secondary Prevention after Ischemic Stroke
NEJM 394:784-792, Frie,K.L.,et al, 2026
Neurosyphilis with Abnormal in the Bilateral Pons and Multifocal Cranial Nerve Enhancement
Ann Neurol 99:283-284, Zhang,Y.,et al, 2026
Patterns and Factors Associated with Cerebral Infarction on MRi in Tuberculous Meningitis: Secondary Anlysis of the ACT-TBM Trial
Stroke 57:856-864, Chandu,M.,et al, 2026
Asundexian for Secondary Stroke Prevention
NEJM 394:1467-1479, 1540, Sharm,M.,et al, 2026
Deep Venous Dural Arteriovenous Fistula Mimicking Progressive Dementia
Stroke 57:e180-181, Langlois-Therien,T.,et al, 2026